{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:12:20Z","timestamp":1788423140283,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,8,30]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The emergence of Monkeypox Virus (MPXV) as a major global health\nconcern underscores an urgent unmet need for innovative antiviral therapeutics. To address this need,\na novel large-scale in silico screening strategy was adopted to identify highly potent antiviral cyclic\npeptides that inhibit the A42R profilin-like protein of monkeypox virus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 5,115 cyclic peptides were initially screened using Tanimoto similarity analysis,\nfollowed by data clustering to ensure structural diversity. From this, 500 representative peptides were\nselected and subjected to molecular docking against the A42R profilin-like protein. Subsequently,\ndensity functional theory calculations were performed to evaluate electronic properties. The topranked\npeptides were further analyzed using 300 ns molecular dynamics simulations conducted in\ntriplicate to ensure reproducibility. Advanced analyses, including steered molecular dynamics, umbrella\nsampling, and MM\/GBSA binding free energy calculations, were performed to assess the stability\nand binding affinity of the peptide\u2013protein complexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Molecular docking identified 12 cyclic peptides with binding energies \u2264 \u22126.0 kcal\/mol\n(\u22126.5 to \u22126.1 kcal\/mol), with CycPept_5184 showing the lowest score (\u22126.5 kcal\/mol). Molecular\ndynamics simulations revealed that CycPept_3468 and CycPept_4348 maintained stable binding\n(RMSD of 1 nm), whereas CycPept_5184 and CycPept_5604 exhibited large fluctuations (up to 10\nnm), indicating dissociation after 40 ns. MM\/GBSA analysis confirmed favorable binding for both\nstable complexes, with CycPept_4348 showing a more negative binding free energy (\u221231.94 \u00b1 5.01\nkcal\/mol) than CycPept_3468 (\u221226.09 \u00b1 3.74 kcal\/mol), driven primarily by stronger electrostatic\ninteractions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>A multi-step computational screening strategy has been successfully used to narrow the\nlarge peptide library down to only two potent cyclic peptides. The combination of techniques in this\nsimulation, including docking simulations, DFT methods, long-timescale MD simulations, and binding\nfree energy calculations, improves the reliability of the predicted binding interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The objective of the present study was to identify cyclic peptides CycPept_3468 and\nCycPept_4348, which showed excellent inhibitory activity against the MPXV A42R profilin-like\nprotein. The high binding affinity and structural stability of the peptides indicate their potential efficacy\nas antiviral drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501473387260824100136","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:36:59Z","timestamp":1788187019000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus"],"prefix":"10.2174","volume":"27","author":[{"given":"Ahmad","family":"Firoz","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia"},{"name":"Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani S. H.","family":"Mohammed Ali","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia"},{"name":"Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology, King Abdulaziz University,Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501473387260824100136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/257817\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501473387260824100136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:14:27Z","timestamp":1788419667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/257817\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501473387260824100136","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}